Clinical Trial Operating System

The unified operating layer for clinical trials.

Protocol, data, operations, and monetization — orchestrated as one adaptive system. CTOS sits above the engines and decides what to do next.

What is CTOS

The governing intelligence above all trial functions.

At its core: the Adaptive Intelligence Engine — answering the question no existing platform can.

“Given where I am right now — what should I do next, and what will it cost me if I don't?”
Adaptive Intelligence Engine · core question

Decision states

  • Stop — efficacy achievedPrimary endpoint met
  • Stop — futility thresholdConditional power below boundary
  • Adapt — enrichment neededSubgroup response warrants amendment
  • Continue — monitorOn track for next interim

Architecture

Three layers. One system.

Protocol design feeds adaptive execution. Adaptive execution feeds the marketplace. Each layer compounds the next.

Layer I

Protocol intelligence

  • Protocol authoring
  • Deviation prediction
  • Amendment analysis
  • Submission prep

Layer II

Adaptive execution

  • Real-time monitoring
  • Adaptive interim analysis
  • DSMB auto-alerts
  • Multi-site normalization

Layer III

Trial-to-token

  • Tokenized data assets
  • Fractional licensing
  • T2T exchange
  • On-chain provenance

Data monetization

The trial-to-token marketplace.

The most valuable and underutilized asset in healthcare — unlocked.

SponsorsMonetize data assets beyond the primary endpoint.
CROsLicense anonymized outcome data for benchmarking.
BuyersInstitutional access to validated, trial-grade data.

Competitive advantage

Why CTOS can't be replicated.

  • 01

    Composition

    The engines weren't bolted together — they were architected as one system, sharing a data model and event bus from day one.

  • 02

    Integration density

    Eight engines with deep interdependencies — years of compounding architecture.

  • 03

    First-mover in T2T

    No platform offers a tokenized clinical data exchange today.